PODCAST: A Biotech Buyout, and an Influencer Uprising
By Doug Young & Rene Vanguestaine AstraZeneca has offered to buy money-losing Gracell Biotech for up to $1.2 billion, in a first-of-its kind M&A for a Chinese drug startup. Will…
China Education Group seeks to jumpstart growth with resumed M&A
The vocational school operator has recently raised funds to expand its network, as its growth slowed in the first half of its latest fiscal year Key Takeaways: China Education Group’s…
Fast-growing Duoning Biotech seeks winning formula for pricey IPO
The provider of bioprocessing services for the drugs sector has been expanding rapidly via aggressive M&A, backed by big-name investors Key Takeaways: WuXi Biologics is Duoning Biotechnology’s biggest client and…
Boqii Cuddles Up to Premium U.S. Pet Food Maker
Online pet community operator signals intent to make more strategic investments as it buys undisclosed stake in Better Choice Key Points: Boqii’s investment in U.S. premium pet food maker Better…